Clinical Trial Update: Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study [Phase 2]

View source ↗

Summary

A Phase II trial evaluating adjuvant capecitabine in elderly breast cancer patients; the study is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Jules Bordet Institute | Conditions: Elderly Patients, Breast Cancer | Phase 2 | Status: COMPLETED